"Toxoplasmosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The acquired form of infection by Toxoplasma gondii in animals and man.
| Descriptor ID |
D014123
|
| MeSH Number(s) |
C03.752.250.800
|
| Concept/Terms |
Toxoplasmosis- Toxoplasmosis
- Toxoplasmoses
- Toxoplasma gondii Infection
- Infection, Toxoplasma gondii
- Infections, Toxoplasma gondii
- Toxoplasma gondii Infections
|
Below are MeSH descriptors whose meaning is more general than "Toxoplasmosis".
Below are MeSH descriptors whose meaning is more specific than "Toxoplasmosis".
This graph shows the total number of publications written about "Toxoplasmosis" by people in this website by year, and whether "Toxoplasmosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Toxoplasmosis" by people in Profiles.
-
Zhou Y, Fomovska A, Muench S, Lai BS, Mui E, McLeod R. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2014; 58(3):1789-92.
-
Stec J, Fomovska A, Afanador GA, Muench SP, Zhou Y, Lai BS, El Bissati K, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Sommervile C, Woods S, Roberts CW, Rice D, Prigge ST, McLeod R, Kozikowski AP. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem. 2013 Jul; 8(7):1138-60.
-
Husseinzadeh H, Cotta CV, Gordon S, Lichtin A. A young woman with enlarged lymph nodes. Cleve Clin J Med. 2013 May; 80(5):276-80.
-
Fomovska A, Wood RD, Mui E, Dubey JP, Ferreira LR, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Welsh WJ, Sommerville C, Woods S, Roberts C, McLeod R. Salicylanilide inhibitors of Toxoplasma gondii. J Med Chem. 2012 Oct 11; 55(19):8375-91.
-
Lai BS, Witola WH, El Bissati K, Zhou Y, Mui E, Fomovska A, McLeod R. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14182-7.
-
Mullarky IK, Szaba FM, Berggren KN, Kummer LW, Wilhelm LB, Parent MA, Johnson LL, Smiley ST. Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infection. Infect Immun. 2006 Feb; 74(2):1181-8.
-
Kretschmer U, Bonhagen K, Debes GF, Mittrücker HW, Erb KJ, Liesenfeld O, Zaiss D, Kamradt T, Syrbe U, Hamann A. Expression of selectin ligands on murine effector and IL-10-producing CD4+ T cells from non-infected and infected tissues. Eur J Immunol. 2004 Nov; 34(11):3070-81.